Browse by Title

22 results found

Type here to filter the list

S
Safety of Anti-infectives

Anne M. Butler, PhD, MS – Washington University School of Medicine ### 1062638###Moderator###Assistant Professor###Washington University School of Medicine###
Moderator: Anne M. Butler, PhD, MS – Washington University School of Medicine
### @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Moderator###Professor###University of Southern Denmark###
Moderator: Anton Pottegård, PhD, DMSc – University of Southern Denmark
###
SARS-CoV-2 infection and risk of subsequent demyelinating diseases – a nationwide register-based cohort study in Sweden

Fredrik Nyberg, MD PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358933###Presenting Author###Professor of Register Epidemiology###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Presenting Author: Fredrik Nyberg, MD PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Snieguole Vingeliene – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325167###Co-Author######Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Snieguole Vingeliene – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Huiqi Li, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1659121###Co-Author###Assoc. Prof.###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Huiqi Li, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Helena Backman – Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325168###Co-Author######Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Helena Backman – Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Ruzan Udumyan, PhD – Clinical Epidemiology and Biostatistics, Department of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. ### 2325169###Co-Author######Clinical Epidemiology and Biostatistics, Department of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.###
Co-Author: Ruzan Udumyan, PhD – Clinical Epidemiology and Biostatistics, Department of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
### @@@ Johan Jendeberg, MD, PhD – Department of Radiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. ### 2325170###Co-Author###Consultant radiologist###Department of Radiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.###
Co-Author: Johan Jendeberg, MD, PhD – Department of Radiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
### @@@ Gunlög Rasmussen – Department of Infectious Diseases, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325171###Co-Author######Department of Infectious Diseases, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Gunlög Rasmussen – Department of Infectious Diseases, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Martin Sundqvist – Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325172###Co-Author######Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Martin Sundqvist – Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Katja Fall – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 1991607###Co-Author######Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Katja Fall – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Ayako Hiyoshi, PhD – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325173###Co-Author######Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Ayako Hiyoshi, PhD – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Scott Montgomery – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325174###Co-Author######Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Scott Montgomery – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
###
Screening of drug-related adverse events by sequence symmetry analysis with spline-based self-controlled case-series design for dose-response relationship: a proof of concept study

Motohiko Adomi, MD, MS – Harvard University ### 2325359###Presenting Author###PhD student###Harvard University###
Presenting Author: Motohiko Adomi, MD, MS – Harvard University
### @@@ Kazuaki Uda – Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan ### 2325364###Co-Author######Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan###
Co-Author: Kazuaki Uda – Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
### @@@ Ryota Inokuchi – University of Tokyo ### 2325360###Co-Author######University of Tokyo###
Co-Author: Ryota Inokuchi – University of Tokyo
### @@@ Nanako Tamiya – University of Tsukuba ### 2325361###Co-Author######University of Tsukuba###
Co-Author: Nanako Tamiya – University of Tsukuba
### @@@ Masao Iwagami – Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan ### 2325365###Co-Author######Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan###
Co-Author: Masao Iwagami – Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
###
SIG Meetings
SIG Meetings
Skin Cancer Risk Associated With Statin Treatment: A Target Trial Emulation Study

Ping Sheng Chou – School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 2325289###Presenting Author###PharmD student###School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Presenting Author: Ping Sheng Chou – School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Avery Shuei-He Yang, MClinicpharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1658473###Co-Author###Master of clinical pharmacy###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Avery Shuei-He Yang, MClinicpharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
Social Evening at Spindler & Klatt
Speaker Ready Room
Speaker Ready Room
Speaker Ready Room
Speaker Ready Room
Speaker Ready Room
Speaker Ready Room
Specification of Time Zero in Causal Inference Studies Using Real-World Data: Challenges and Solutions.

Xabier Garcia de Albeniz Martinez, MD, PhD – RTI Health Solutions ### 1062596###Lead Speaker###Director, Epidemiology###RTI Health Solutions###
Lead Speaker: Xabier Garcia de Albeniz Martinez, MD, PhD – RTI Health Solutions
### @@@ Jaume Aguado, PhD (he/him/his) – RTI Health Solutions ### 1063271###Speaker###Director, Biostatistics###RTI Health Solutions###
Speaker: Jaume Aguado, PhD (he/him/his) – RTI Health Solutions
### he/him/his @@@ Ellen Caniglia, ScD – University of Pennsylvania School of Medicine ### 1655294###Speaker###Assistant Professor###University of Pennsylvania School of Medicine###
Speaker: Ellen Caniglia, ScD – University of Pennsylvania School of Medicine
### @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Speaker###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###
Speaker: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
### @@@ Camille Maringe, PhD – London Scholl of Hygiene & Tropical Medicine ### 1655676###Speaker###Assistant Professor###London Scholl of Hygiene & Tropical Medicine###
Speaker: Camille Maringe, PhD – London Scholl of Hygiene & Tropical Medicine
### @@@ Jonathan Sterne, MSc PhD (he/him/his) – University of Bristol ### 2325178###Speaker###Professor of Medical Statistics and Epidemiology###University of Bristol###
Speaker: Jonathan Sterne, MSc PhD (he/him/his) – University of Bristol
### he/him/his
Spotlight Poster Session A
Spotlight Poster Session B
Spotlight Poster Session C
Stroke Risk Following Receipt of COVID-19 Bivalent Vaccines Among U.S. Adults Aged ≥65 Years

Yun Lu, PhD – Center for Biologics Evaluation and Research, Food and Drug Administration ### 1659299###Presenting Author###Mathematical Statistician###Center for Biologics Evaluation and Research, Food and Drug Administration###
Presenting Author: Yun Lu, PhD – Center for Biologics Evaluation and Research, Food and Drug Administration
### @@@ Kathryn Matuska, BA – Acumen, LLC ### 1659336###Co-Author###Policy Lead###Acumen, LLC###
Co-Author: Kathryn Matuska, BA – Acumen, LLC
### @@@ Gita Nadimpalli, MD, MPH, PhD – Acumen, LLC ### 2325538###Co-Author###Senior Policy Assoicate###Acumen, LLC###
Co-Author: Gita Nadimpalli, MD, MPH, PhD – Acumen, LLC
### @@@ Yuxin Ma – Acumen LLC ### 2325286###Co-Author######Acumen LLC###
Co-Author: Yuxin Ma – Acumen LLC
### @@@ Nathan N. Duma, PhD – Acumen LLC ### 2325539###Co-Author######Acumen LLC###
Co-Author: Nathan N. Duma, PhD – Acumen LLC
### @@@ Henry Zhang – Food and Drug Administration ### 2325540###Co-Author######Food and Drug Administration###
Co-Author: Henry Zhang – Food and Drug Administration
### @@@ Yiyun Chiang, MPH – Acumen LLC ### 2325287###Co-Author###Data and Policy Analyst - Statistical Programmer###Acumen LLC###
Co-Author: Yiyun Chiang, MPH – Acumen LLC
### @@@ Hai Lyu – Acumen., LLC ### 2325541###Co-Author###Policy Associate###Acumen., LLC###
Co-Author: Hai Lyu – Acumen., LLC
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###
Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA ### 1358531###Co-Author######Centers for Medicare & Medicaid Services, Washington, DC, USA###
Co-Author: Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###
Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###
Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
###
Students/Early Career Professionals Meet & Greet
Surprising Benefits of Diabetes Drugs

Phyo T. Htoo, MD, PhD – Brigham and Women's Hospital and Harvard Medical School ### 1655331###Moderator###Instructor in Medicine###Brigham and Women's Hospital and Harvard Medical School###
Moderator: Phyo T. Htoo, MD, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany ### 2328243###Moderator###Associate Professor###Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany###
Moderator: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany
### he/him/his
Switching from warfarin to direct oral anticoagulants in older adults with atrial fibrillation: a US nationwide cohort study

Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Presenting Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA ### 1360618###Co-Author###Professor of Medicine, Harvard Medical School###Massachusetts General Hospital, Boston, MA###
Co-Author: Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA
### @@@ Darae Ko – Hebrew Rehabilitation Center, Harvard Medical School ### 2325571###Co-Author######Hebrew Rehabilitation Center, Harvard Medical School###
Co-Author: Darae Ko – Hebrew Rehabilitation Center, Harvard Medical School
### @@@ Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1658130###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1991377###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Julianna Mastrorilli – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 2325572###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Julianna Mastrorilli – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research ### 1655334###Co-Author###Associate Professor of Medicine, Harvard Medical School###Hebrew SeniorLife Marcus Institute for Aging Research###
Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
###
Switching pattern of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the Italian multi-regional VALORE distributed database network

Giorgia Pellegrini, MS – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330031###Presenting Author###Researcher###Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Presenting Author: Giorgia Pellegrini, MS – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Andrea Spini, PharmD PhD – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330030###Co-Author###Post-doc fellowship###Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Co-Author: Andrea Spini, PharmD PhD – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona ### 1993969###Co-Author###Assistant Professor###Department of Diagnostics and Public Health, University of Verona, Verona###
Co-Author: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
### @@@ Luca L’Abbate – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330034###Co-Author######Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Co-Author: Luca L’Abbate – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Massimo Carollo – University of Verona, Verona ### 2330200###Co-Author######University of Verona, Verona###
Co-Author: Massimo Carollo – University of Verona, Verona
### @@@ Olivia Leoni – Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy ### 2330035###Co-Author######Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy###
Co-Author: Olivia Leoni – Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy
### @@@ Arianna Mazzone – Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy ### 2330036###Co-Author######Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy###
Co-Author: Arianna Mazzone – Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy
### @@@ Domenica Ancona – Centro Regionale Farmacovigilanza Regione Puglia ### 2330037###Co-Author######Centro Regionale Farmacovigilanza Regione Puglia###
Co-Author: Domenica Ancona – Centro Regionale Farmacovigilanza Regione Puglia
### @@@ Paolo Stella – Apulian Regional Health Department, Bari, Italy ### 2330038###Co-Author######Apulian Regional Health Department, Bari, Italy###
Co-Author: Paolo Stella – Apulian Regional Health Department, Bari, Italy
### @@@ Anna Cavazzana – Azienda Zero, Regione Veneto, Italy ### 2330039###Co-Author######Azienda Zero, Regione Veneto, Italy###
Co-Author: Anna Cavazzana – Azienda Zero, Regione Veneto, Italy
### @@@ Angela Scapin – Azienda Zero, Regione Veneto, Italy ### 2330040###Co-Author######Azienda Zero, Regione Veneto, Italy###
Co-Author: Angela Scapin – Azienda Zero, Regione Veneto, Italy
### @@@ Sara Lopes – Department of Epidemiology, Lazio Regional Health Service, Rome, Italy ### 2330041###Co-Author######Department of Epidemiology, Lazio Regional Health Service, Rome, Italy###
Co-Author: Sara Lopes – Department of Epidemiology, Lazio Regional Health Service, Rome, Italy
### @@@ Valeria Belleudi – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service ### 2329370###Co-Author######Department of Epidemiology ASL Roma 1, Lazio Regional Health Service###
Co-Author: Valeria Belleudi – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service
### @@@ Stefano Ledda – Regione Autonoma della Sardegna, Cagliari, Italy ### 2330042###Co-Author######Regione Autonoma della Sardegna, Cagliari, Italy###
Co-Author: Stefano Ledda – Regione Autonoma della Sardegna, Cagliari, Italy
### @@@ Paolo Carta – Regione Autonoma della Sardegna, Cagliari, Italy ### 2330043###Co-Author######Regione Autonoma della Sardegna, Cagliari, Italy###
Co-Author: Paolo Carta – Regione Autonoma della Sardegna, Cagliari, Italy
### @@@ Paola Rossi – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy ### 2330044###Co-Author######Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy###
Co-Author: Paola Rossi – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy
### @@@ Lucian Ejlli – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy ### 2330045###Co-Author######Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy###
Co-Author: Lucian Ejlli – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy
### @@@ Ester Sapigni – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy ### 2330046###Co-Author######Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy###
Co-Author: Ester Sapigni – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy
### @@@ Aurora Puccini – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy ### 2330047###Co-Author######Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy###
Co-Author: Aurora Puccini – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy
### @@@ Claudio Guarneri – claudio.guarneri@unime.it ### 2330993###Co-Author######claudio.guarneri@unime.it###
Co-Author: Claudio Guarneri – claudio.guarneri@unime.it
### @@@ Paolo Gisondi – paolo.gisondi@univr.it ### 2330994###Co-Author######paolo.gisondi@univr.it###
Co-Author: Paolo Gisondi – paolo.gisondi@univr.it
### @@@ Stefania Spila Alegiani – Italian National Institute of Health ### 2329364###Co-Author######Italian National Institute of Health###
Co-Author: Stefania Spila Alegiani – Italian National Institute of Health
### @@@ Marco Massari – Italian National Institute of Health ### 2329371###Co-Author######Italian National Institute of Health###
Co-Author: Marco Massari – Italian National Institute of Health
### @@@ Gianluca Trifirò, MD, FISPE – Università di Verona ### 1302766###Co-Author###Full Professor of Pharmacology###Università di Verona###
Co-Author: Gianluca Trifirò, MD, FISPE – Università di Verona
###